🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, prospective, single arm, non-randomized, open-label,...
Status
Active Not Recruiting
Location
A.Z. Sint Jan AV
Start Date
2021-06-11
Trial ID
NCT04842877
Treatments Being Tested
Rational, objective and design: Some cancer-protecting genes are inactivate...
Status
Recruiting
Location
Gustave Roussy
Start Date
2026-03-05
Trial ID
NCT07303387
Treatments Being Tested
This study will assess the safety and tolerability of valemetostat in combi...
Status
Recruiting
Location
University of California San Diego Moores Cancer Center
Start Date
2025-12-03
Trial ID
NCT07244341
Treatments Being Tested
This study will characterize the safety and clinical benefit of valemetosta...
Status
Active Not Recruiting
Location
City Of Hope National Medical Center
Start Date
2021-06-03
Trial ID
NCT04703192
Treatments Being Tested
This study will evaluate the safety, tolerability, and efficacy of valemeto...
Status
Active Not Recruiting
Location
City of Hope At Orange County Lennar Foundation Cancer Center
Start Date
2024-02-16
Trial ID
NCT06244485
Treatments Being Tested
This is a phase Ib/II, dose escalation and dose expansion study of valemeto...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-07-29
Trial ID
NCT06294548
Treatments Being Tested
This study will compare Valemetostat Tosylate Plus Pembrolizumab vs Pembrol...
Status
Active Not Recruiting
Location
University of California San Diego (Ucsd)-Moores Cancer Center
Start Date
2024-10-30
Trial ID
NCT06644768
Treatments Being Tested
This Phase 2 study will be conducted to assess the efficacy and safety of v...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2019-11-21
Trial ID
NCT04102150
Treatments Being Tested
This phase II trial evaluates whether genetic testing in prostate cancer is...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-02-06
Trial ID
NCT06632977
This study will test whether valemetostat in combination with atezolizumab ...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-01-29
Trial ID
NCT06807632
Treatments Being Tested